1. A combination therapy for KRAS-mutant lung cancer by targeting synthetic lethal partners of mutant KRAS. Issue 1 (December 2016) Authors: Pang, Xiufeng; Liu, Mingyao Journal: Chinese journal of cancer Issue: Volume 35:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A combination therapy for KRAS‐mutant lung cancer by targeting synthetic lethal partners of mutant KRAS. Issue 1 (28th October 2016) Authors: Pang, Xiufeng; Liu, Mingyao Journal: Cancer communications Issue: Volume 35:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Comparison of reinforcement learning and model predictive control for building energy system optimization. (25th June 2023) Authors: Wang, Dan; Zheng, Wanfu; Wang, Zhe; Wang, Yaran; Pang, Xiufeng; Wang, Wei Journal: Applied thermal engineering Issue: Volume 228(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Defeat mutant KRAS with synthetic lethality. (2nd October 2017) Authors: Pang, Xiufeng; Liu, Mingyao Journal: Small GTPases Issue: Volume 8:Number 4(2017) Page Start: 212 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Design, synthesis and anticancer activities of novel otobain derivatives. Issue 1 (23rd November 2015) Authors: Li, Zhongzhou; Su, Hui; Yu, Weiwei; Li, Xinjun; Cheng, Hao; Liu, Mingyao; Pang, Xiufeng; Zou, Xinzhuo Journal: Organic & biomolecular chemistry Issue: Volume 14:Issue 1(2016) Page Start: 277 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Experimentally-determined characteristics of radiant systems for office buildings. (1st July 2018) Authors: Jia, Hongyuan; Pang, Xiufeng; Haves, Philip Journal: Applied energy Issue: Volume 221(2018) Page Start: 41 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Inhibition of histone deacetylases sensitizes EGF receptor‐TK inhibitor‐resistant non‐small‐cell lung cancer cells to erlotinib in vitro and in vivo. (24th August 2017) Authors: Yu, Weiwei; Lu, Weiqiang; Chen, Guoliang; Cheng, Feixiong; Su, Hui; Chen, Yihua; Liu, Mingyao; Pang, Xiufeng Journal: British journal of pharmacology Issue: Volume 174:Number 20(2017) Page Start: 3608 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Quantitative and systems pharmacology 2. In silico polypharmacology of G protein-coupled receptor ligands via network-based approaches. (March 2018) Authors: Wu, Zengrui; Lu, Weiqiang; Yu, Weiwei; Wang, Tianduanyi; Li, Weihua; Liu, Guixia; Zhang, Hankun; Pang, Xiufeng; Huang, Jin; Liu, Mingyao; Cheng, Feixiong; Tang, Yun Journal: Pharmacological research Issue: Volume 129(2018) Page Start: 400 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Saponins extracted from by‐product of Asparagus officinalis L. suppress tumour cell migration and invasion through targeting Rho GTPase signalling pathway. (28th February 2013) Authors: Wang, Jieqiong; Liu, Yali; Zhao, Jingjing; Zhang, Wen; Pang, Xiufeng Journal: Journal of the science of food and agriculture Issue: Volume 93:Number 6(2013:Apr. 15) Page Start: 1492 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Sporoderm-Broken Spores of Ganoderma lucidum Inhibit the Growth of Lung Cancer: Involvement of the Akt/mTOR Signaling Pathway. (2nd October 2016) Authors: Chen, Yali; Lv, Jing; Li, Kun; Xu, Jing; Li, Mingyan; Zhang, Wen; Pang, Xiufeng Journal: Nutrition and cancer Issue: Volume 68:Number 7(2016) Page Start: 1151 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗